概念板块个股详情
基因编辑 添加自选

基因编辑是一种新兴的比较精确的能对生物体基因组特定目标基因进行修饰的一种基因工程技术或过程,在基因研究、基因治疗和遗传改良等方面展示出了巨大的潜力。 该概念板块包含了业务涉及基因编辑的主要美股上市公司。

  • 1378.861
  • +6.034+0.44%
收盘价 11/21 16:00 (美东)
1384.054最高价1361.376最低价
成分股: 10只领涨股: NTLA+5.18%
分时
  • 5日
  • 日K
  • 周K
  • 月K
  • 季K
  • 年K
成分股
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
自选
NTLAIntellia Therapeutics
13.8000.680+5.18%397.09万5514.11万13.23013.12014.39013.23014.06亿13.88亿1.02亿1.01亿-8.73%-13.75%-12.93%-38.26%-41.33%-55.53%-54.74%--3.95%亏损亏损8.84%生物技术
A安捷伦科技
132.0603.490+2.71%288.22万3.79亿129.710128.570132.190129.060379.44亿378.09亿2.87亿2.86亿+1.41%-5.42%+1.05%-6.23%+0.85%+5.01%-4.53%0.71%1.01%27.4631.522.43%诊断与研究
CRBUCaribou Biosciences
1.9800.020+1.02%114.38万225.81万2.0001.9602.0391.9101.79亿1.62亿9055.27万8157.88万-5.26%-28.78%+8.79%-5.26%-7.69%-65.02%-65.45%--1.40%亏损亏损6.58%生物技术
APLSApellis Pharmaceuticals
27.7500.260+0.95%153.63万4217.24万26.99627.49028.14026.62034.52亿23.41亿1.24亿8435.56万-1.10%-3.44%+0.62%-27.32%-30.82%-42.67%-53.64%--1.82%亏损亏损5.53%生物技术
SGMOSangamo Therapeutics
1.9600.010+0.51%330.05万647.51万1.9501.9502.0301.8904.09亿4.00亿2.09亿2.04亿-8.84%-30.25%+31.54%+148.10%+236.31%+412.95%+260.76%--1.62%亏损亏损7.18%生物技术
VRTX福泰制药
450.370-0.860-0.19%150.78万6.77亿454.240451.230455.430445.0001159.83亿1156.50亿2.58亿2.57亿-6.94%-10.37%-4.56%-8.04%-4.21%+27.57%+10.69%--0.59%亏损32.422.31%生物技术
EDITEditas Medicine
2.370-0.040-1.66%289.31万686.35万2.4502.4102.4702.3001.96亿1.83亿8254.81万7732.38万-14.44%-25.24%-25.47%-35.60%-56.19%-77.60%-76.60%--3.74%亏损亏损7.05%生物技术
BLUEbluebird bio
0.298-0.005-1.68%387.23万114.93万0.3100.3030.3140.2905792.50万5765.70万1.94亿1.94亿-17.84%-22.04%-40.31%-52.21%-69.08%-92.34%-78.41%--2.00%亏损亏损7.89%生物技术
CRSPCRISPR Therapeutics
46.290-0.970-2.05%209.46万9670.44万47.21047.26047.21045.51039.51亿38.75亿8535.35万8371.83万-1.20%-10.77%-3.46%-2.51%-19.00%-33.84%-26.05%--2.50%亏损亏损3.60%生物技术
BEAMBeam Therapeutics
23.580-0.910-3.72%101.02万2399.83万24.53024.49024.71023.33019.53亿16.18亿8280.56万6863.38万-10.38%-9.66%+6.75%-9.48%-3.28%-20.53%-13.37%--1.47%亏损亏损5.64%生物技术